Monthly Archives: July 2018

http://www.lslog.com/pfizers-rejig-made-for-growth-but-its-also-handy-for-a-future-split-executives/Pfizer's rejig made for growth, but it's also handy for a future split: executives

Pfizer's rejig made for growth, but it's also handy for a future split: executives

Pfizer’s rejig made for growth, but it’s also handy for a future split: executives Pfizer’s new three-unit structure may be all about driving growth for now. But don’t count out […]

http://www.lslog.com/active-bio-and-tevas-laquinimod-fails-once-more-now-in-huntingtons-disease/Active Bio and Teva’s laquinimod fails once more, now in Huntington’s disease

Active Bio and Teva’s laquinimod fails once more, now in Huntington’s disease

Active Bio and Teva’s laquinimod fails once more, now in Huntington’s disease Active Biotech and Teva delivered more bad news from their clinical development of laquinimod, this time from a […]

http://www.lslog.com/thanks-to-genzyme-and-no-thanks-to-vaccines-or-diabetes-sanofi-is-treading-water/Thanks to Genzyme—and no thanks to vaccines or diabetes—Sanofi is treading water

Thanks to Genzyme—and no thanks to vaccines or diabetes—Sanofi is treading water

Thanks to Genzyme—and no thanks to vaccines or diabetes—Sanofi is treading water As much as Sanofi has struggled with diabetes and generic drugs the past few years, it could typically […]

http://www.lslog.com/european-backing-for-mercks-keytruda-rubs-salt-in-bristol-myers-wounds/European backing for Merck's Keytruda rubs salt in Bristol-Myers' wounds

European backing for Merck's Keytruda rubs salt in Bristol-Myers' wounds

European backing for Merck’s Keytruda rubs salt in Bristol-Myers’ wounds Merck’s Keytruda is one step closer to extending its dominance in the all-important previously untreated lung cancer market. On Monday, […]

http://www.lslog.com/nebraska-lawmaker-urges-pfizer-to-sue-over-use-of-its-drugs-in-lethal-injection-procedure/Nebraska lawmaker urges Pfizer to sue over use of its drugs in lethal injection procedure

Nebraska lawmaker urges Pfizer to sue over use of its drugs in lethal injection procedure

Nebraska lawmaker urges Pfizer to sue over use of its drugs in lethal injection procedure “Time is of the essence,” a Nebraska lawmaker wrote to Pfizer in an attempt to […]

http://www.lslog.com/after-its-recent-funding-round-hifibio-pens-takeda-rd-collaboration/After its recent funding round, HiFiBiO pens Takeda R&D collaboration

After its recent funding round, HiFiBiO pens Takeda R&D collaboration

After its recent funding round, HiFiBiO pens Takeda R&D collaboration HiFiBiO Therapeutics has signed a deal with Japanese Big Pharma and biotech friend Takeda to work on antibody therapies for […]

http://www.lslog.com/freshly-funded-ifm-therapeutics-defines-emerging-target-for-fighting-inflammatory-disease/Freshly funded IFM Therapeutics defines emerging target for fighting inflammatory disease

Freshly funded IFM Therapeutics defines emerging target for fighting inflammatory disease

Freshly funded IFM Therapeutics defines emerging target for fighting inflammatory disease Just two weeks after hauling in a $31 million series A funding round to form a new subsidiary, Boston-based […]

http://www.lslog.com/tevas-picked-an-address-in-parsippany-new-jersey-and-the-dirts-about-to-fly/Teva's picked an address in Parsippany, New Jersey, and the dirt's about to fly

Teva's picked an address in Parsippany, New Jersey, and the dirt's about to fly

Teva’s picked an address in Parsippany, New Jersey, and the dirt’s about to fly Teva now knows where it’s headed in New Jersey, but it’s still got plenty of work […]

http://www.lslog.com/as-humira-competition-nears-abbvies-imbruvica-and-mavyret-pick-up-steam/As Humira competition nears, AbbVie's Imbruvica and Mavyret pick up steam

As Humira competition nears, AbbVie's Imbruvica and Mavyret pick up steam

As Humira competition nears, AbbVie’s Imbruvica and Mavyret pick up steam AbbVie is bracing for European biosimilar competition to Humira, but the drug is still continuing its upward trajectory. In […]

http://www.lslog.com/achaogen-wields-ax-on-rd-c-suite-as-antibiotic-launch-gets-underway/Achaogen wields ax on R&D, C-suite as antibiotic launch gets underway

Achaogen wields ax on R&D, C-suite as antibiotic launch gets underway

Achaogen wields ax on R&D, C-suite as antibiotic launch gets underway The impact of Achaogen’s narrower-than-expected label for antibiotic Zemdri is now apparent: The biotech has slashed 28% of its […]